Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermacool Forte is a high-strength topical cooling cream formulation containing 5% levomenthol in an aqueous base, specifically designed for the symptomatic relief of severe pruritus (itching). It is commonly utilized for patients with skin conditions such as eczema, dermatitis, urticaria, or pruritus ani/vulvae where standard moisturizers are insufficient. The therapeutic effect is mediated through the activation of Transient Receptor Potential Melastatin 8 (TRPM8) receptors located on sensory neurons in the skin. When applied topically, the levomenthol triggers these cold-sensitive ion channels, producing a cooling sensation that competes with and alleviates the perception of itch, providing a localized counter-irritant effect without the need for systemic or corticosteroid intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dermacool Forte.